LITAF and breast cancer: <i>In vivo</i>, nude mice were used to explore the effect of LITAF on tumor response to PTX treatment.<h4>Results</h4>PCMT1 and COX-2 were upregulated in BC tissues, particularly in PTX-resistant patients, whereas LITAF expression was downregulated.